Overweight or obesity Trials in Chicago, United States
Conditions / Overweight or obesity / Chicago, United States
Overweight or obesity has been the subject of sustained clinical investigation across multiple research sites.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04726293 | Anti-inflammatory Effect and Associated Mechanisms of Mango Consumption | COMPLETED | NA |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight | RECRUITING | — |
| NCT03548935 | STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity | COMPLETED | PHASE3 |
| NCT05234125 | Better Lifestyle Counseling for African American Women During Pregnancy | RECRUITING | NA |
| NCT04228978 | Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss | RECRUITING | — |
| NCT04100200 | Berries, Inflammation, and Gut Microbiome | ACTIVE_NOT_RECRUITING | NA |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) | RECRUITING | PHASE4 |
| NCT05936151 | A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT06499857 | Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation | RECRUITING | PHASE3 |